Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1199-1203

  Goodman Jr , Oscar B ^a   Barwe, Sonali P ^b   Ritter, Brigitte ^c   McPherson, Peter S ^c   Vasko, Ann Jeanette ^d   Keen, James H ^d   Nanus, David M ^a   Bander, Neil H ^a   Rajasekaran, Ayyappan K ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Clathrin; Endocytosis; Prostate cancer; Prostate specific membrane antigen

Indexed keywords

ADAPTOR PROTEIN; CLATHRIN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BINDING SITE; CELL LINE; CHEMISTRY; COATED VESICLE; DOG; ENDOCYTOSIS; MALE; MOUSE; PHYSIOLOGY;

ADAPTOR PROTEIN COMPLEX 2; ANIMALS; ANTIGENS, SURFACE; BINDING SITES; CELL LINE; CLATHRIN; CLATHRIN-COATED VESICLES; DOGS; ENDOCYTOSIS; GLUTAMATE CARBOXYPEPTIDASE II; MALE; MICE;

EID: 38449110057     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Heston WD: Characterization and glutamyl preferring carboxy-peptidase function of prostate specific membrane antigen: a novel folate hydrolase. Urology 49: 104-112, 1997.
2. Israeli RS, Powell CT, Fair WR and Heston WD: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230, 1993.
3. Pinto JT, Suffoletto BP, Berzin TM, et al: Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 2: 1445-1451, 1996.
4. Mahadevan D and Saldanha JW: The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: implications for drug design. Protein Sci 8: 2546-2549, 1999.
5. Schulke N, Varlamova OA, Donovan GP, et al: The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci USA 100: 12590-12595, 2003.
6. Lapidus RG, Tiffany CW, Isaacs JT and Slusher BS: Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate 45: 350-354, 2000.
7. Murphy GP, Elgamal AA, Su SL, Bostwick DG and Holmes EH: Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer 83: 2259-2269, 1998.
8. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS and Gaudin PB: Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59: 3192-3198, 1999.
9. Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH and Rajasekaran AK: Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res 63: 2645-2648, 2003.
10. Liu H, Rajasekaran AK, Moy P, et al: Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res 58: 4055-4060, 1998.
11. Rajasekaran SA, Anilkumar G, Oshima E, et al: A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell 14: 4835-4845, 2003.
12. Liu H, Moy P, Kim S, et al: Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 57: 3629-3634, 1997.
13. Christiansen JJ, Rajasekaran SA, Moy P, et al: Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate 55: 9-19, 2003.
14. Zaremba S and Keen JH: Assembly polypeptides from coated vesicles mediate reassembly of unique clathrin coats. J Cell Biol 97: 1339-1347, 1983.
15. Lodge PA, Childs RA, Monahan SJ, et al: Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cells. J Immunother 22: 346-355, 1999.
16. Goodman OB Jr, Krupnick JG, Gurevich VV, Benovic JL and Keen JH: Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain. J Biol Chem 272: 15017-15022, 1997.
17. Ritter B, Denisov AY, Philie J, Deprez C, Tung EC, Gehring K and McPherson PS: Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2. EMBO J 23: 3701-3710, 2004.
18. Ritter B, Philie J, Girard M, Tung EC, Blondeau F and McPherson PS: Identification of a family of endocytic proteins that define a new alpha-adaptin ear-binding motif. EMBO Rep 4: 1089-1095, 2003.
19. Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA and Rajasekaran AK: Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell 16: 1082-1094, 2005.
20. Angelisova P, Drbal K, Horejsi V and Cerny J: Association of CD10/neutral endopeptidase 24.11 with membrane micro domains rich in glycosylphosphatidylinositol-anchored proteins and Lyn kinase. Blood 93: 1437-1439, 1999.
21. Kibbey RG, Rizo J, Gierasch LM and Anderson RG: The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation. J Cell Biol 142: 59-67, 1998.
22. Heuser JE and Keen J: Deep-etch visualization of proteins involved in clathrin assembly. J Cell Biol 107: 877-886, 1988.
23. ter Haar E, Musacchio A, Harrison SC and Kirchhausen T: Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker. Cell 95: 563-573, 1998.
24. Scheele U, Alves J, Frank R, Duwel M, Kalthoff C and Ungewickell E: Molecular and functional characterization of clathrin- and AP-2-binding determinants within a disordered domain of auxilin. J Biol Chem 278: 25357-25368, 2003.
25. Scheele U, Kalthoff C and Ungewickell E: Multiple interactions of auxilin 1 with clathrin and the AP-2 adaptor complex. J Biol Chem 276: 36131-36138, 2001.
26. Legendre-Guillemin V, Metzler M, Charbonneau M, et al: HIP1 and HIP12 display differential binding to F-actin, AP2, and clathrin. Identification of a novel interaction with clathrin light chain. J Biol Chem 277: 19897-19904, 2002.
27. Waelter S, Scherzinger E, Hasenbank R, et al: The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis. Hum Mol Genet 10: 1807-1817, 2001.
28. Laporte SA, Miller WE, Kim KM and Caron MG: β-arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin. J Biol Chem 277: 9247-9254, 2002.
29. Kim KM, Gainetdinov RR, Laporte SA, Caron MG and Barak LS: G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J Biol Chem 280: 12774-12780, 2005.
30. Rao DS, Hyun TS, Kumar PD, et al: Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 110: 351-360, 2002.